| Model Number |
5071-35 |
| Medical Device Problem Code |
Over-Sensing (1438)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
05/27/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that five days post implant of an implantable pulse generator (ipg) system, the atrial and ventricular oversensing was noted on the a stored episode.It was noted that the right atrial (ra) lead exhibited far field r-wave (ffrw) oversensing and that the right ventricular (rv) lead exhibited t-wave oversensing (twos).Both leads remain in use.No patient complications have been reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Continuation of d10: 200h14 tissue valve; implant date: (b)(6) 2026.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|